AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 29 filers reported holding AC IMMUNE SA in Q3 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231 | -3.3% | 80,701 | 0.0% | 0.01% | +9.1% |
| Q2 2023 | $239 | +55.2% | 80,701 | +22.6% | 0.01% | +37.5% |
| Q1 2023 | $154 | +79.1% | 65,803 | +54.9% | 0.01% | +60.0% |
| Q4 2022 | $86 | -99.9% | 42,488 | +92.6% | 0.01% | +25.0% |
| Q3 2022 | $69,000 | -13.8% | 22,056 | -1.0% | 0.00% | 0.0% |
| Q2 2022 | $80,000 | -7.0% | 22,287 | +3.1% | 0.00% | 0.0% |
| Q1 2022 | $86,000 | -66.0% | 21,617 | -57.6% | 0.00% | -60.0% |
| Q4 2021 | $253,000 | -27.5% | 51,021 | -1.9% | 0.01% | -33.3% |
| Q3 2021 | $349,000 | -38.6% | 52,019 | -27.4% | 0.02% | -40.0% |
| Q2 2021 | $568,000 | +4.4% | 71,650 | +0.3% | 0.02% | -10.7% |
| Q1 2021 | $544,000 | +79.5% | 71,430 | +22.6% | 0.03% | +64.7% |
| Q4 2020 | $303,000 | +11.0% | 58,285 | +4.5% | 0.02% | -5.6% |
| Q3 2020 | $273,000 | +259.2% | 55,769 | +392.9% | 0.02% | +200.0% |
| Q2 2020 | $76,000 | -6.2% | 11,314 | -3.1% | 0.01% | -14.3% |
| Q1 2020 | $81,000 | -20.6% | 11,677 | -2.4% | 0.01% | 0.0% |
| Q4 2019 | $102,000 | – | 11,963 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 11,297,911 | $55,925,000 | 5.88% |
| Prosight Management, LP | 1,248,453 | $6,180,000 | 3.43% |
| PA Capital LLC | 76,257 | $377,000 | 0.37% |
| Artal Group S.A. | 1,000,000 | $4,950,000 | 0.20% |
| Temasek Holdings (Private) Ltd | 2,614,095 | $12,940,000 | 0.10% |
| COHEN LAWRENCE B | 13,350 | $66,000 | 0.04% |
| Tekla Capital Management LLC | 171,813 | $850,000 | 0.04% |
| Athanor Capital, LP | 108,540 | $537,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 28,600 | $142,000 | 0.02% |
| APPLETON PARTNERS INC/MA | 11,525 | $57,000 | 0.01% |